BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8927447)

  • 1. Cytological diagnosis of serous effusions in a cancer hospital in Brazil.
    Oyafuso MS; Longatto Filho A; Bortolan J; Rahal P; Bisi H; Lombardo V
    Pathologica; 1996 Apr; 88(2):128-31. PubMed ID: 8927447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of molecular genetics to the diagnosis of lymphoid-rich effusions: study of 95 cases with concomitant immunophenotyping.
    Mihaescu A; Gebhard S; Chaubert P; Rochat MC; Braunschweig R; Bosman FT; Delacrétaz F; Benhattar J
    Diagn Cytopathol; 2002 Aug; 27(2):90-5. PubMed ID: 12203875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of pericellular lacunae in cell blocks of effusions.
    Price BA; Ehya H; Lee JH
    Acta Cytol; 1992; 36(3):333-7. PubMed ID: 1580117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of toluidine blue-stained wet films in effusion cytology.
    Erkiliç S; Koçer NE
    Acta Cytol; 2006; 50(4):407-9. PubMed ID: 16901004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oncologic diagnosis of serous effusions in body cavities (cytologic study and evaluation of cholesterol and carcinoembryonic antigen levels)].
    Gulyás M; Elek G; Molnár M; Szollár L
    Orv Hetil; 1995 Nov; 136(45):2453-8. PubMed ID: 8524550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytology of fluids from pleural, peritoneal and pericardial cavities in children. A comprehensive survey.
    Hallman JR; Geisinger KR
    Acta Cytol; 1994; 38(2):209-17. PubMed ID: 8147212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
    Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of effusion cytology in patients with simultaneous malignancy and ascites.
    Jha R; Shrestha HG; Sayami G; Pradhan SB
    Kathmandu Univ Med J (KUMJ); 2006; 4(4):483-7. PubMed ID: 18603959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cell block for body cavity fluids: do the results justify the cost?
    Jonasson JG; Ducatman BS; Wang HH
    Mod Pathol; 1990 Nov; 3(6):667-70. PubMed ID: 1702212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclassification of lymphoproliferative disorders in serous effusions: a 10-year experience.
    Tong LC; Ko HM; Saieg MA; Boerner S; Geddie WR; da Cunha Santos G
    Cancer Cytopathol; 2013 May; 121(5):261-70. PubMed ID: 23460311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
    Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
    Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions.
    Kentrou NA; Tsagarakis NJ; Tzanetou K; Damala M; Papadimitriou KA; Skoumi D; Stratigaki A; Anagnostopoulos NI; Malamou-Lada E; Athanassiadou P; Paterakis G
    Cytometry B Clin Cytom; 2011 Sep; 80(5):324-34. PubMed ID: 21695775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
    Afify A; Lynne LC; Howell L
    Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
    Illei PB; Ladanyi M; Rusch VW; Zakowski MF
    Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytological variations observed in the malignant cells in body cavity fluids].
    Matsuda M
    Rinsho Byori; 1990 Nov; Suppl 87():69-85. PubMed ID: 2287091
    [No Abstract]   [Full Text] [Related]  

  • 18. Utility of the thromboplastin-plasma cell-block technique for fine-needle aspiration and serous effusions.
    Kulkarni MB; Desai SB; Ajit D; Chinoy RF
    Diagn Cytopathol; 2009 Feb; 37(2):86-90. PubMed ID: 19021217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of clot examination for malignant cells in serous effusions.
    Jalal R; Aftab K; Hasan SH; Pervez S
    Cytopathology; 2009 Aug; 20(4):231-4. PubMed ID: 18627403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions.
    Lonardi S; Manera C; Marucci R; Santoro A; Lorenzi L; Facchetti F
    Diagn Cytopathol; 2011 May; 39(5):313-7. PubMed ID: 21488172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.